Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM2 | Q14416 | 2/20 | 0.36 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.32 |
| ▸ | FEN1 | P39748 | 1/20 | 0.32 |
| ▸ | CETP | P11597 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17177805 | 0.97 | GRM2 (0.36) | GRM2ALOX5APFEN1CETP | |
| SCHEMBL21374508 | 0.94 | GRM2 (0.34) | GRM2ALOX5APFEN1 | |
| SCHEMBL15497674 | 0.94 | GRM2 (0.32) | GRM2 | |
| SCHEMBL16710254 | 0.94 | GRM2 (0.36) | GRM2ALOX5APFEN1 | |
| SCHEMBL16167874 | 0.91 | GRM2 (0.39) | GRM2ALOX5APFEN1 | |
| SCHEMBL20275802 | 0.90 | GRM2 (0.38) | GRM2ALOX5APFEN1 | |
| SCHEMBL16710255 | 0.89 | GRM2 (0.34) | GRM2ALOX5APFEN1 | |
| SCHEMBL20275807 | 0.89 | GRM2 (0.35) | GRM2ALOX5APFEN1CETP | |
| SCHEMBL14888020 | 0.89 | GRM2 (0.35) | GRM2ALOX5APFEN1CETP | |
| SCHEMBL17033202 | 0.88 | GRM2 (0.33) | GRM2ALOX5APFEN1CETP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200299581-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL SWITCHING DEVICE USING SAME | JNC CORPORATION (JP) | 2020-09-24 | — | — | US | disclosed |
| US-10633589-B2 | Liquid crystal medium, optical device and liquid crystal compound | JNC CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
| US-20190316036-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | JNC CORPORATION (JP) | 2019-10-17 | — | — | US | disclosed |
| EP-2586764-B1 | COMPOUND HAVING BRANCHED ALKYL OR BRANCHED ALKENYL, OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL ELEMENT | JNC CORP (JP) | 2019-09-18 | — | — | EP | disclosed |
| US-10308870-B2 | Liquid crystal medium, optical device and liquid crystal compound | JNC CORPORATION (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20180112131-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE AND LIQUID CRYSTAL COMPOUND | JNC CORPORATION (JP) | 2018-04-26 | — | — | US | disclosed |
| US-9738831-B2 | Optically isotropic liquid crystal composition and optical device | JNC CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9738831-B2 | Optically isotropic liquid crystal composition and optical device | JNC CORPORATION (JP) | 2017-08-22 | — | — | US | disclosed |
| US-9611429-B2 | Liquid crystal medium, optical device and liquid crystal compound | JNC CORPORATION (JP) | 2017-04-04 | — | — | US | disclosed |
| US-9611429-B2 | Liquid crystal medium, optical device and liquid crystal compound | JNC CORPORATION (JP) | 2017-04-04 | — | — | US | disclosed |
| US-9593094-B2 | Liquid crystal medium, optical device, and liquid crystal compound | JNC CORPORATION (JP) | 2017-03-14 | — | — | US | disclosed |
| US-20160304784-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE AND LIQUID CRYSTAL COMPOUND | JNC CORPORATION (JP) | 2016-10-20 | — | — | US | disclosed |
| US-20160122648-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE AND LIQUID CRYSTAL COMPOUND | JNC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160122648-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE AND LIQUID CRYSTAL COMPOUND | JNC CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160002536-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE, AND LIQUID CRYSTAL COMPOUND | JNC PETROCHEMICAL CORPORATION (JP) | 2016-01-07 | — | — | US | disclosed |
| US-20150240159-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL DEVICE | JNC CORPORATION (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150240159-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL DEVICE | JNC CORPORATION (JP) | 2015-08-27 | — | — | US | disclosed |
| US-20150129800-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | MERCK PATENT GMBH (DE) | 2015-05-14 | — | — | US | disclosed |
| US-20130114009-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130114009-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL MEDIUM AND OPTICAL DEVICE | JNC PETROCHEMICAL CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10308870-B2 | Liquid crystal medium, optical device and liquid crystal compound | OCIAD1, HCN3, HCN1 | GRM2 2308/4885ALOX5AP 2798/4885FEN1 3182/4885 |
| US-20160002536-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE, AND LIQUID CRYSTAL COMPOUND | HCN1, HCN3, HCN2 | GRM2 2151/4885ALOX5AP 1630/4885FEN1 2132/4885 |
| US-20150129800-A1 | LIQUID CRYSTAL MEDIUM AND LIQUID CRYSTAL DISPLAY | CCND2, CFD, CRY1 | GRM2 2026/4885ALOX5AP 2885/4885FEN1 4353/4885 |
| US-20150240159-A1 | OPTICALLY ISOTROPIC LIQUID CRYSTAL COMPOSITION AND OPTICAL DEVICE | SCO2, CNOT1, LEO1 | GRM2 1980/4885ALOX5AP 456/4885FEN1 1516/4885 |
| US-20160304784-A1 | LIQUID CRYSTAL MEDIUM, OPTICAL DEVICE AND LIQUID CRYSTAL COMPOUND | HCN1, PIEZO1, NCS1 | GRM2 1606/4885ALOX5AP 2522/4885FEN1 2590/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.